Skip to main content
. 2014 Jun 1;14(6):e17417. doi: 10.5812/hepatmon.17417

Table 1. Characteristics of Patients Under Dialysis in Tabriz According to Hepatitis C Virus Infection and Patients With Seroconversion During the Dialysis Treatment.

- HCV a Status Seroconversion Status
HCV Positive HCV Negative P Value Seroconversion to HCV Positive No Change P Value
Total, No. % 37 (8.1) 418 (91.9) - 18 (3.9) 437 (96.1) -
Mean Age ± SD 50.35 ± 12.345 56.48 ± 15.829 0.020 51.11 ± 13.03 56.19 ± 15.73 0.176
Married 32 (86.5) 385 (92.3) 0.210 16 (88.9) 401 (91.8) 0.665
Peritoneal dialysis 0 29 (6.9) 0.090 0 29 (6.6) 0.254
Diabetes 4 (10.8) 167 (63.9) 0.002 3 (16.7) 168 (38.4) 0.163
Blood transfusion 31 (83.8) 267 (63.9) < 0.001 13 (72.2) 285 (65.2) 0.495
Renal transplantation 18 (48.6) 39 (9.3) 0.005 8 (44.4) 49 (11.2) < 0.001
Contact with HBV a infection 0 19 (4.5) 0.320 0 19 (4.3) 0.394
Sexual multi partner 0 1 (2.7) 0.910 0 1 (2) 0.956
IVDU a 1 (2.7) 3 (7) 0.213 1 (5.6) 11 (2.5) 0.713
Tattooing 1 (2.7) 10 (2.4) 0.900 0 11 (2.5) 0.495
Surgical intervention 31 (83.8) 303 (72.5) 0.135 17 (94.4) 317 (72.5) 0.032
Duration of dialysis 138.41 ± 80.579 34.90 ± 34.105 < 0.001 106.06 ± 55.519 40.73 ± 46.845 < 0.0001
Number of dialysis session per week - - - - - -
One 0 12 (2.9) 0.290 0 15 (3.4) 0.541
More than one 37 (100) 403 (97.1) 0.290 18 (100) 422 (96.6) 0.423

a Abbreviations: HCV, Hepatitis C virus; HBV, Hepatitis B virus; IVDU, Intravenous Drug User.